Skip to main content
CVKD filings

Corporate insider profile

Quang X Pham Filing Activity

Latest reported as Chairman, CEO and Interim CFO of Cadrenal Therapeutics, Inc. (CVKD).

Purchase filings
0
Reported companies
1
Net open-market value
-$365,869.10
Latest transaction
Jun 26, 2026

Affiliated corporations

Reported company relationships

Transaction history

Open-market Transactions

Open-market insider purchase and sale transactions
DateCompanyRoleTypeSharesPriceTotal value
Jun 26, 2026Cadrenal Therapeutics, Inc. (CVKD)Chairman, CEO and Interim CFOSale11,156$3.04$33,920
Jun 23, 2026Cadrenal Therapeutics, Inc. (CVKD)Chairman, CEO and Interim CFOSale11,444$3.48$39,830
Jun 17, 2026Cadrenal Therapeutics, Inc. (CVKD)Chairman, CEO and Interim CFOSale4,126$3.18$13,110